Michael Petusky
Stock Analyst at Barrington Research
(2.30)
# 2,667
Out of 5,146 analysts
226
Total ratings
42.16%
Success rate
-1.89%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSIC Henry Schein | Maintains: Outperform | $79 → $97 | $81.91 | +18.42% | 19 | Feb 25, 2026 | |
| USPH U.S. Physical Therapy | Maintains: Outperform | $103 | $81.80 | +25.92% | 27 | Feb 20, 2026 | |
| LMAT LeMaitre Vascular | Maintains: Outperform | $95 | $91.21 | +4.16% | 14 | Feb 20, 2026 | |
| OFIX Orthofix Medical | Maintains: Outperform | $18 | $13.05 | +37.93% | 5 | Feb 17, 2026 | |
| BVS Bioventus | Initiates: Outperform | $13 | $8.74 | +48.74% | 1 | Feb 9, 2026 | |
| HAE Haemonetics | Maintains: Outperform | $93 → $94 | $62.46 | +50.50% | 36 | Feb 6, 2026 | |
| OPCH Option Care Health | Maintains: Outperform | $38 → $42 | $33.51 | +25.34% | 19 | Jan 16, 2026 | |
| ANIK Anika Therapeutics | Maintains: Outperform | $16 | $10.96 | +46.05% | 21 | Jan 9, 2026 | |
| VRME VerifyMe | Maintains: Outperform | $1 → $1.5 | $0.99 | +51.81% | 11 | Jan 6, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $14 | $12.80 | +9.38% | 27 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $106 | $79.29 | +33.69% | 25 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $2.25 | $1.18 | +90.68% | 15 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $7.31 | - | 6 | Aug 28, 2024 |
Henry Schein
Feb 25, 2026
Maintains: Outperform
Price Target: $79 → $97
Current: $81.91
Upside: +18.42%
U.S. Physical Therapy
Feb 20, 2026
Maintains: Outperform
Price Target: $103
Current: $81.80
Upside: +25.92%
LeMaitre Vascular
Feb 20, 2026
Maintains: Outperform
Price Target: $95
Current: $91.21
Upside: +4.16%
Orthofix Medical
Feb 17, 2026
Maintains: Outperform
Price Target: $18
Current: $13.05
Upside: +37.93%
Bioventus
Feb 9, 2026
Initiates: Outperform
Price Target: $13
Current: $8.74
Upside: +48.74%
Haemonetics
Feb 6, 2026
Maintains: Outperform
Price Target: $93 → $94
Current: $62.46
Upside: +50.50%
Option Care Health
Jan 16, 2026
Maintains: Outperform
Price Target: $38 → $42
Current: $33.51
Upside: +25.34%
Anika Therapeutics
Jan 9, 2026
Maintains: Outperform
Price Target: $16
Current: $10.96
Upside: +46.05%
VerifyMe
Jan 6, 2026
Maintains: Outperform
Price Target: $1 → $1.5
Current: $0.99
Upside: +51.81%
DENTSPLY SIRONA
Jan 5, 2026
Maintains: Outperform
Price Target: $14
Current: $12.80
Upside: +9.38%
Nov 14, 2025
Maintains: Outperform
Price Target: $106
Current: $79.29
Upside: +33.69%
Oct 30, 2025
Maintains: Outperform
Price Target: $2.25
Current: $1.18
Upside: +90.68%
Aug 28, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $7.31
Upside: -